| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.059 | 0.4 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |